In prima dimidium MMXXII, exportantur salutem products ut Korean medicina, medicinae apparatu et stibio pervenit recordum altum. Covi XIX Diagnostic Reagents et vaccina boost exportantur.
Secundum ad Korea Health Industry Development Institutum (Khidi), in industria exportantur ducenti $ 13.35 billion in primo dimidium huius anni. Quod instar erat autem 8.5% from $ 12.3 billion in anno-ante quartam et erat summum dimidium-anno effectus eventus semper. Non memoriae super $ 13.15 billion in secunda dimidium MMXXI.
Per industriam, pharmaceutical exportationum $ 4.35 billion, usque 45.0% a US $ 3.0 billion in eodem tempore in MMXXI. Exports of Medical cogitationes ad USD 4.93 billion, usque 5.2% anno in anno. Ob quarentenam in Sina, Cosmetics exportantur cecidit a 11.9% ad $ 4.06 billion.
Denucts in pharmaceutical exportat exportantur per Biopharmaceuticals et vaccines. Exports of Biopharmaceuticals ad $ 1.68 billion, cum exportantur vaccina ad $ DCCLXXX million. Et propter 56,4% omnium pharmaceutical exportat. In particulari, exportantur vaccina auctus per 490.8% anno-on-anno debitum ad expansionem exportantur de Vaccines contra Covi-XIX producitur in contractus vestibulum.
In agro medicinae cogitationes, diagnostic reagentia propter maxima participes, reaching $ 2.48 billion, usque 2.8% ab eodem tempore in MMXXI ($ CCCXC million) et X-ray ($ CCCXC million) et X-$ CCCXC.
Post tempus: Aug-23-2022